MED-PHARMA
0818.652.680 · rovalta.com · 25/09/2026
MED-PHARMA
Financial year 2024 · Closed on 31/12/2024
Overview
Identity
Source · BCE/KBOMED-PHARMA is a Private company with limited liability incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0818.652.680
- Incorporation
- 18/09/2009
- Legal form
- Private company with limited liability
- Registered office
- Rue Eloy 86A
1070 Anderlecht · BruxellesSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2024
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 30,5 k € | -32.5% | 45,2 k € | -10.4% | 50,4 k € | +8.4% | 46,5 k € | -12.5% | 53,1 k € |
| EBITDA | 29,3 k € | -33.3% | 43,9 k € | -10.8% | 49,2 k € | +7.9% | 45,6 k € | -10.8% | 51,2 k € |
| Operating result | 28,8 k € | -33.5% | 43,4 k € | -10.5% | 48,5 k € | +8.0% | 44,9 k € | -11.2% | 50,5 k € |
| Net result | 27,9 k € | -9.7% | 30,9 k € | +4.3% | 29,6 k € | -3.3% | 30,6 k € | -6.7% | 32,8 k € |
| Balance sheet | |||||||||
| Equity | 743,3 k € | +3.9% | 715,4 k € | +4.5% | 684,6 k € | +4.5% | 655 k € | +4.9% | 624,4 k € |
| Total assets | 983,9 k € | +2.9% | 956,3 k € | +5.4% | 907,4 k € | +2.1% | 888,7 k € | +3.1% | 862 k € |
| Cash | – | 91 € | – | – | 840 € | ||||
| Debts | 239,7 k € | -0.5% | 240,9 k € | +8.1% | 222,9 k € | -4.6% | 233,7 k € | -1.6% | 237,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20241 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
Rue Eloy 86A 1070 Anderlecht| Company | CBE no. |
|---|---|
PHARMACIE DELEM● Active | 0436.965.303 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2025 | 05/11/2024 | 24/10/2023 | 29/10/2022 | 28/10/2021 | 30/11/2020 |
| General meeting | 16/06/2025 | 17/06/2024 | 19/06/2023 | 20/06/2022 | 26/10/2021 | 13/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 16/06/2025 | 30/09/2025 | French | |
| Micro model | 31/12/2023 | 17/06/2024 | 05/11/2024 | French | |
| Micro model | 31/12/2022 | 19/06/2023 | 24/10/2023 | French | |
| Micro model | 31/12/2021 | 20/06/2022 | 29/10/2022 | French | |
| Micro model | 31/12/2020 | 26/10/2021 | 28/10/2021 | French | |
| Micro model | 31/12/2019 | 13/11/2020 | 30/11/2020 | French | |
| Micro model | 31/12/2018 | 17/06/2019 | 15/10/2019 | French | |
| Micro model | 31/12/2017 | 30/06/2018 | 31/08/2018 | French | |
| Abridged model | 31/12/2016 | 20/06/2017 | 31/08/2017 | French | |
| Abridged model | 31/12/2015 | 30/08/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 15/06/2015 | 29/09/2015 | French | |
| Abridged model | 31/12/2013 | 16/06/2014 | 11/09/2014 | French | |
| Abridged model | 31/12/2012 | 17/06/2013 | 19/07/2013 | French | |
| Abridged model | 31/12/2011 | 18/06/2012 | 29/08/2012 | French | |
| Abridged model | 31/12/2010 | 20/06/2011 | 30/08/2011 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other29/09/2009RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 202427,9 k €↓
- 2023Annual accounts 202330,9 k €↑
- 2022Annual accounts 202229,6 k €↓
- 2021Annual accounts 202130,6 k €↓
- 2020Annual accounts 202032,8 k €↑
- 2019Annual accounts 201920,2 k €↓
- 2018Annual accounts 201822,7 k €↓
- 2017Annual accounts 201737 k €↑
- 2016Annual accounts 20168,9 k €↓
- 2015Annual accounts 201532,2 k €↓
- 2014Annual accounts 201432,9 k €↑
- 2013Annual accounts 201330,2 k €↑
- 2012Annual accounts 201226 k €↓
- 2011Annual accounts 201138,6 k €↓
- 2010Annual accounts 2010349,5 k €
- 18/09/2009IncorporationPrivate company with limited liability